APA (7th ed.) Citation

Batran, S. a., Hofheinz, R., Reichart, A., Pauligk, C., Schönherr, C., Schlag, R., . . . Götze, T. (2021). Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. International journal of cancer, 148(6), . https://doi.org/10.1002/ijc.33336

Chicago Style (17th ed.) Citation

Batran, Salah-Eddin al-, et al. "Quality of Life and Outcome of Patients with Metastatic Pancreatic Cancer Receiving First-line Chemotherapy with Nab-paclitaxel and Gemcitabine: Real-life Results from the Prospective QOLIXANE Trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer Registry." International Journal of Cancer 148, no. 6 (2021). https://doi.org/10.1002/ijc.33336.

MLA (9th ed.) Citation

Batran, Salah-Eddin al-, et al. "Quality of Life and Outcome of Patients with Metastatic Pancreatic Cancer Receiving First-line Chemotherapy with Nab-paclitaxel and Gemcitabine: Real-life Results from the Prospective QOLIXANE Trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer Registry." International Journal of Cancer, vol. 148, no. 6, 2021, https://doi.org/10.1002/ijc.33336.